World Cancer Day 2012: EAHP and ESOP issue joint call for pharmacist development to advance cancer care

Press release: WORLD CANCER DAY 2012

On the eve of World Cancer Day the European Association of Hospital Pharmacists (EAHP) and the European Society of Oncology Pharmacy (ESOP) issued a joint call for hospital pharmacist development in order to further advance cancer patient care and outcomes.

Press RELEASE

Brussels, 3 February 2012

Release: Immediate

WORLD CANCER DAY 2012: EAHP AND ESOP ISSUE JOINT CALL FOR PHARMACIST DEVELOPMENT TO ADVANCE CANCER CARE

On the eve of World Cancer Day the European Association of Hospital Pharmacists (EAHP) and the European Society of Oncology Pharmacy (ESOP) issued a joint call for hospital pharmacist development in order to further advance cancer patient care and outcomes.

Pharmacists play a key part in cancer care in such roles as medical oncology, haematology, palliative care and chemotherapy preparation services. Appropriately trained and competent pharmacists are responsible for accurate preparation, dispensing and clinical verification of patients’ chemotherapy, targeted therapy and supportive medication orders. 

However both EAHP and ESOP are ambitious to see further development of the pharmacist’s role in cancer treatment and see unrealised opportunities at the European and national level for increasing the input of pharmacist expertise to treatment decisions and the patient experience. The two organisations have therefore issued a short 5 point summary of recommendations to national and international health policy makers:

1. Recognise the need to encourage the role of the pharmacist in multiprofessional cancer care teams. This helps to ensure flexibility of service, best use of workforce skills and best outcomes for patients;

2. Promote the concept of having a lead oncology pharmacist in cancer centres to manage and organise pharmaceutical care;

3. Develop and implement clear Standards in the management and assessment of chemotherapy treatment and the quality of oncology clinical pharmacy service provision;

4. Appreciate the specialised nature of hospital pharmacy, and the hospital pharmacist’s particular expertise in working with specialised and novel medications; and,

5. Support high standards in hospital pharmacy service through the development of accredited and certified hospital pharmacy qualifications, including oncology

Dr Roberto Frontini, President of the EAHP said: “Every one of us is affected by cancer and all of us will know someone taken by this prevalent class of disease. We all therefore have a direct stake in seeing continuous improvement of cancer care across Europe. Central to achieving that is advancing the role of the hospital pharmacist in the treatment pathway. EAHP and ESOP’s 5 point plan provides a framework that we urge health policy makers to give thought to on World Cancer Day as they consider how to improve cancer care in their jurisdiction.” 

Klaus Meier, President of ESOP said: “Improving the standard of cancer care in Europe requires close collaboration across professions, health systems and countries. ESOP and EAHP are working together to raise educational and service standards in hospital and oncology pharmacy across all our member countries. However, to achieve this in full we need the support of health policy planners at all levels. We hope this 5 point plan can form a basis for securing greater levels of practical support.”

ENDS

For further information please contact Richard Price, EAHP Policy and Advocacy Officer

Tel.: +32 (0)2/741.68.35 Email: po@eahp.eu

Notes to Editors:

1. The European Association of Hospital Pharmacists (EAHP) is a working community of national associations of hospital pharmacists. Its membership includes representatives of national hospital pharmacy associations in almost all the European Union (EU) member states, in addition to Switzerland, Norway, Serbia, Turkey, Croatia, the Former Yugoslav Republic Of Macedonia (FYROM) and Bosnia Herzegovina . Membership is increasing each year and, at present, EAHP represents the interest of over 21,000 hospital pharmacists in 31 countries all over Europe. www.eahp.eu



2. The European Society of Oncology Pharmacy (ESOP) is constituted of 31 member countries and has 2,600 members. The Society’s primary aim is to support the optimal treatment for cancer patients. It does this by developing and promoting clinical and oncology pharmacy practice and making information on knowledge and achievements in cancer treatment and activities available to the public. In this area it has, for example, developed the quality standard of oncology service pharmacy (QuapoS). www.esop.eu



3. World Cancer Day is marked on February 4 to raise awareness of cancer and to encourage its prevention, detection, and treatment. It is led by the Union for International Cancer Control, a global consortium of more than 470 cancer-fighting organisations in over 120 countries. www.worldcancerday.org



4. The 17th Annual Congress of the European Association of Hospital Pharmacists will be held in Milan 21-23 March.



More information here http://www.eahp.eu/Congresses/2012-Congress-Milan-Italy



5. The first scientific conference of ESOP, together with the European CanCer Organisation (ECCO), the European Conference of Oncology Pharmacy (ECOP), will be held in Budapest September 27th to 29th 2012.



More information here: http://www.ecco-org.eu/Conferences/Conferences/ECOP-2012/~/media/ECCO%20documents/ECCO%20sections/Congresses%20and%20Conferences/ECOP%202012/LR_110155_ECOP2012_progr_overview_V02.ashx

Source

http://www.eahp.eu/News/Our-News/Press-release-WORLD-CANCER-DAY-2012

European Association of Hospital Pharmacists (EAHP) celebrates 40 years

European Association of Hospital Pharmacists (EAHP) will be celebrating its 40th Anniversary in 2012.

To mark this occasion, EAHP will be preparing a comprehensive history of the association.

European Association of Hospital Pharmacists is a working community of national associations of hospital pharmacists. Its membership includes representatives of national hospital pharmacy associations in almost all the European Union (EU) member states, in addition to Switzerland, Norway, Serbia, Turkey, Croatia, the Former Yugoslav Republic Of Macedonia (FYROM) and Bosnia Herzegovina .

Membership is increasing each year and, at present, EAHP represents the interest of over 21,000 hospital pharmacists in 31 countries all over Europe.

At a scientific congress in Strasbourg a number of hospital pharmacists from different European countries decided that they should establish a new European association to represent their common interests. Thus in 1969, the seeds of EAHP were sown. On 6 March 1972, the representatives of six European countries signed the first Statutes of the European Association of Hospital Pharmacists, in The Hague, The Netherlands.

The first President of EAHP was Marcel Lebas from France. The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands. In 1973, Ireland and Spain joined EAHP, soon followed by Norway, Greece, Austria, Sweden and Switzerland. In the 1990s, Italy, Portugal, Hungary, Luxembourg, Finland, Slovakia, Slovenia and the Czech Republic became members. More recently, Bulgaria and Bosnia Herzegovina became members of EAHP. Membership within EAHP is open to countries members of the Council of Europe. On the 1st of August 2011, the EAHP officially became an International Not-for-Profit Organization, and adjusted its policy to better face modern challenges.

Message of the President

40th Anniversary of EAHP: The Past and the Future

Dr. Roberto Frontini, President

Source

EAHP

Merry Christmas!

+
XXX
XXXXX
XXXXXXX
XXXXXXXXX
"BUON ANNO"
"JOYEUX NOEL"
"VESELE VANOCE"
"MELE KALIKIMAKA"
"NODLAG SONA DHUIT"
"BLWYDDYN NEWYDD DDA"
"GOD JUL"
"FELIZ NATAL"
"BOAS FESTAS"
"FELIZ NAVIDAD"
"MERRY CHRISTMAS"
"ΚΑΛΑ ΧΡΙΣΤΟΥΓΕΝΝΑ"
"KALA CHRISTOUGENA"
"VROLIJK KERSTFEEST"
"FROHLICHE WEIHNACHTEN"
"BUON NATALE-GODT NYTAR"
"HUAN YING SHENG TAN CHIEH"
"WESOLYCH SWIAT-SRETAN BOZIC"
"MOADIM LESIMHA-LINKSMU KALEDU"
"HAUSKAA JOULUA-AID SAID MOUBARK"
"'N PRETTIG KERSTMIS"
"ONNZLLISTA UUTTA VUOTTA"
"Z ROZHDESTYOM KHRYSTOVYM"
"NADOLIG LLAWEN-GOTT NYTTSAR"
"FELIC NADAL-GOJAN KRISTNASKON"
"S NOVYM GODOM-FELIZ ANO NUEVO"
"GLEDILEG JOL-NOELINIZ KUTLU OLSUM"
"EEN GELUKKIG NIEUWJAAR-SRETAN BOSIC"
"KRIHSTLINDJA GEZUAR-KALA CHRISTOUGENA"
"SELAMAT HARI NATAL - LAHNINGU NAJU METU"
"SARBATORI FERICITE-BUON ANNO"
"ZORIONEKO GABON-HRISTOS SE RODI"
"BOLDOG KARACSONNY-VESELE VIANOCE "
"MERRY CHRISTMAS - - HAPPY NEW YEAR"
"ROOMSAID JOULU PUHI -KUNG HO SHENG TEN"
"FELICES PASUAS-EIN GLUCKICHES NEWJAHR"
"PRIECIGUS ZIEMAN SVETKUS SARBATORI VESLLE"
"BONNE ANNEBLWYDDYN NEWYDD DDADRFELIZ NATAL"
XXXXX
XXXXX
XXXXX

European Medicines Agency (EMA) formalises interaction with healthcare professionals

The European Medicines Agency has set out its plans to establish regular interaction with a network of European organisations representing doctors, nurses and pharmacists. In the framework for interaction between the European Medicines Agency and healthcare professionals, published today, the Agency describes its plans to:

• access the best possible independent expertise in matters related to medicines;
• contribute to more efficient and targeted communication to healthcare professionals;
• enhance the understanding of the European Union (EU) medicines regulatory network by healthcare professional organisations.

Organisations will need to fulfil a range of criteria in order to be able to be involved in the Agency's activities. These include being representative of healthcare professionals across the EU or European Economic Area (EEA), a specific interest in medicines, and transparency over sources of funding.

The Agency has been interacting with healthcare professionals since it was founded in 1995, but the new framework for interaction aims to make this relationship more structured and complete. As part of its implementation, the Agency will transform its Healthcare Professionals' Working Group (HCPWG), which has been meeting since 2006, into a working party with links to all scientific committees dealing with human medicines.

The framework of interaction and criteria to be fulfilled by healthcare professionals' organisations were endorsed by the Agency's Management Board on 15 December 2011.

Source

Pharmanews.eu

The European Association of Hospital Pharmacists (EAHP) announces new publisher for the European Journal of Hospital Pharmacy

The European Association of Hospital Pharmacists (EAHP) announces a new partnership with the BMJ Group to publish the peer review journal European Journal of Hospital Pharmacy: Science and Practice (EJHP), launching in January 2012.

The existing journals EJHP Science and EJHP Practice will be combined to make the new journal.

Learn more about this exciting development from the EAHP President and Editor in Chief.

Benefits provided by the new journal include:

· Knowledge – the journal will concentrate on scientific content which will help you in your daily practice and professional content which will develop your career

· In-depth – coverage of all aspects of hospital pharmacy including clinical, therapeutic, economic and social disciplines giving you the full picture

· Ease – all the information that you require will be in one easy to read journal saving you time

EJHP will become more and more an educational tool answering the emerging questions of the pharmacy profession and will also continue to give updated information on professional and political developments.

Find out what the EAHP President’s views are on this new exciting development.

To submit a new paper, become a reviewer or for further information, please visit ejhp.bmj.com.


Source

EAHP

Connectathon 2012 to be held in Bern, Switzerland

More than 300 IT professionals from 70 companies are expected to attend the Twelfth Annual IHE Conntectathon, to be held next year at the Bern Expo in Bern, Switzerland from May 21 to May 25.

“The decision to bring the Connectathon in Switzerland is a fantastic opportunity for stakeholders to move eHealth activities forward in our country and to continue to make interoperability progress in Europe,” said Christian Hay, user Co-Chair of IHE Suisse.

[See also: Connectathon expands to weeklong program]

The event is an intensive “connectivity marathon” for testing the interoperability of health information systems. Companies implementing IHE Technical Framework Profile specifications in their products will have a chance to test their applications with systems from other vendors.

Connectathon will also offer a full program of workshops and meetings, bringing together stakeholders from European health IT projects. In addition, a major eHealth day conference will be held on May 24.

Results from Connectathon are published on the IHE-Europe website. Vendors are able to refer to the IHE Integration Statements to show compliance of their products with IHE Integration Profiles.

[See also: IHE pharmacy trials a 'step forward' for medication integration ]


Sources

Healthcareitnews.com

http://gazelle.ihe.net/content/ihe-european-connectathon-2012

http://www.ihe.net/

http://www.ihe-europe.net/connectathon/133/cat-2012

The European Journal of Hospital Pharmacy: Science and Practice

The European Association of Hospital Pharmacists (EAHP) announces a new partnership with the BMJ Group to publish the peer review journal European Journal of Hospital Pharmacy: Science and Practice (EJHP), launching in January 2012.

The existing journals EJHP Science and EJHP Practice will be combined to make the new journal.

Learn more about this exciting development from the EAHP President and Editor in Chief.

Benefits provided by the new journal include:

· Knowledge – the journal will concentrate on scientific content which will help you in your daily practice and professional content which will develop your career

· In-depth – coverage of all aspects of hospital pharmacy including clinical, therapeutic, economic and social disciplines giving you the full picture

· Ease – all the information that you require will be in one easy to read journal saving you time

EJHP will become more and more an educational tool answering the emerging questions of the pharmacy profession and will also continue to give updated information on professional and political developments.

Find out what the EAHP President’s views are on this new exciting development.

To submit a new paper, become a reviewer or for further information, please visit ejhp.bmj.com.

Please note: authors who have submitted papers after 1st September 2011 to EJHP Science or EJHP Practice will need to re-submit to EJHP: Science and Practice using the new Instructions for Authors.

Sources

http://www.eahp.eu/

http://journals.bmj.com/site/marketing/ejhp/index.xhtml